Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$472K Buy
4,410
+2,145
+95% +$236K ﹤0.01% 707
2026
Q1
$238K Sell
2,265
-13,328
-85% -$1.57M ﹤0.01% 819
2025
Q4
$1.95M Buy
15,593
+1,974
+14% +$235K 0.01% 457
2025
Q3
$1.63M Sell
13,619
-68,729
-83% -$7.26M 0.01% 482
2025
Q2
$7.56M Buy
82,348
+14,407
+21% +$1.31M 0.04% 226
2025
Q1
$5.98M Buy
67,941
+5,320
+8% +$523K 0.03% 237
2024
Q4
$5.79M Buy
62,621
+829
+1% +$79.8K 0.03% 241
2024
Q3
$5.73M Buy
+61,792
New +$5.19M 0.03% 242

Other funds holding CRH

Scotia Capital's CRH Position: Q2 2026 in Review

Scotia Capital increased its CRH (CRH) stake by 95% in Q2 2026, buying an estimated $236K and bringing the position to 4,410 shares worth $472K. The position accounts for ﹤0.01% of the portfolio, ranked #707.

Scotia Capital first reported a position in CRH in Q3 2024 and has held it in 8 quarters since. The position peaked at $7.56M in Q2 2025. 1,023 funds tracked by Wall St. Rank hold CRH as of Q2 2026.

  • Scotia Capital held 4,410 shares of CRH worth $472K as of Q2 2026.
  • Scotia Capital bought 2,145 CRH shares in Q2 2026, an estimated $236K.
  • CRH made up ﹤0.01% of Scotia Capital's portfolio in Q2 2026, its #707 holding.
  • Scotia Capital first reported a position in CRH in Q3 2024 and has held it in 8 quarters since.
  • Scotia Capital's CRH position peaked at $7.56M in Q2 2025.
  • 1,023 funds tracked by Wall St. Rank held CRH as of Q2 2026.

Based on Scotia Capital's 13F filing for Q2 2026, filed 11 Aug 2026.